The CEO of Daxor (DXR) Michael Feldschuh talks about his company, shares of which began trading on the Nasdaq Wednesday, Feb. 2, 2022. Founded in 1971, Daxor is a global leader in blood volume measurement technology and specializes in blood volume testing, which is pivotal to the healthcare industry. The company has a market cap of $45.28M and manufactures the first diagnostic blood test that has been cleared by the FDA
03 Feb 2022
Morning Trade Live
14 Nov 2022
Market On Close
23 Jan 2023
The Watch List
20 Jan 2023
The Watch List
22 Jan 2023
The Watch List
04 Jan 2023
Morning Trade Live
05 Jan 2023